| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
23 |
| issn |
1687-8450
1687-8469 |
| pageRange |
737981-23 |
| publicationName |
Journal of Oncology |
| startingPage |
737981 |
| bibliographicCitation |
Hiss D. Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways. Journal of Oncology. 2012;2012():1–23. doi: 10.1155/2012/737981. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_11604cf63397dc870d819564e1336da2 |
| date |
2012 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/PMC3306947
https://pubmed.ncbi.nlm.nih.gov/22481932
https://doi.org/10.1155/2012/737981 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1687-8450
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35709
https://portal.issn.org/resource/ISSN/1687-8469 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8752
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_533622b82f51bc5431a771c088f3bdd9
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_6f3ef4a5ab86c1588ba1fc89f4c730bb |